High levels of cholesterol are generally considered to be associated with atherosclerosis. In
the past two decades, however, a number of studies have shown that excess cholesterol …

The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD‐related
cirrhosis in the United States and globally highlights the need to better understand the …

Non-alcoholic fatty liver disease (NAFLD) is a quickly emerging global health problem
representing the most common chronic liver disease in the world. Atherosclerotic …

Lipids encompass a wide variety of molecules such as fatty acids, sterols, phospholipids,
and triglycerides. These molecules represent a highly efficient energy resource and can act …

Inflammation and lipid signaling are intertwined modulators of homeostasis and immunity. In
addition to the extensively studied eicosanoids and inositol phospholipids, emerging studies …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of hepatic
histopathological changes ranging from non-inflammatory intracellular fat deposition to non …

Emerging experimental and human evidence has linked altered hepatic cholesterol
homeostasis and free cholesterol (FC) accumulation to the pathogenesis of non-alcoholic …

The circadian clock controls metabolic and physiological processes through finely tuned
molecular mechanisms. The clock is remarkably plastic and adapts to exogenous" …

Non-alcoholic fatty liver disease (NAFLD) is a major health problem associated with obesity
and other features of the metabolic syndrome including insulin resistance and dyslipidemia …

Gestational diabetes mellitus (GDM) is a form of diabetes that is first recognised during
pregnancy, with no evidence of pre-existing type 1 or type 2 diabetes. The prevalence of …